2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences
XTalks
DECEMBER 24, 2020
The pandemic propelled the life science and healthcare sectors onto center stage, and they rose to the occasion against the most unprecedented health challenge in recent times. For example, investment in mRNA vaccines and viral vectors came well before January, many years before it. Here is a review of what 2020 served up.
Let's personalize your content